Early Detection of the Recombinant SARS-CoV-2 XAN Variant in Bulgaria: Initial Genomic Insights into Yet Another Piece of the Growing Puzzle of Recombinant Clades

The first recombinant SARS-CoV-2 variants were identified in 2022, causing public health concerns. The importance of recombinant variants has increased especially since the WHO designated the recombinant variant XBB and its lineages as subvariants that require monitoring on 20 November 2022. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexiev, Ivailo, Ivanov, Ivan, Giovanetti, Marta, Cella, Eleonora, Stoikov, Ivan, Donchev, Deyan, Grigorova, Lyubomira, Gancheva, Anna, Dimitrova, Reneta, Scarpa, Fabio, Korsun, Neli, Trifonova, Ivelina, Dobrinov, Veselin, Kantardjiev, Todor, Christova, Iva, Ciccozzi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457977/
https://www.ncbi.nlm.nih.gov/pubmed/37630601
http://dx.doi.org/10.3390/microorganisms11082041
Descripción
Sumario:The first recombinant SARS-CoV-2 variants were identified in 2022, causing public health concerns. The importance of recombinant variants has increased especially since the WHO designated the recombinant variant XBB and its lineages as subvariants that require monitoring on 20 November 2022. In this study, we provide the first insights into the new SARS-CoV-2 variant named XAN, a recombinant composed of Omicron sub-lineages BA.2 and BA.5. To our knowledge, this is the first report on the recombinant SARS-CoV-2 XAN variant identified in Bulgaria.

Ejemplares similares